• Santen Pharmaceutical Co.

    Santen Pharmaceutical Co., Ltd. announced that Japan's Ministry of Health, Labour and Welfare has granted manufacturing and marketing clearance to Tapros Mini Ophthalmic Solution 0.0015%  (tafluprost) for the treatment of glaucoma and ocular hypertension.

    Tapros Mini Ophthalmic Solution 0.0015% is a preservative-free prostaglandin analogue containing the same active ingredient, tafluprost, at the same concentration as Tapros Ophthalmic Solution 0.0015%, which was launched in 2008.